ASH 2025 Leukemia Highlights PARADIGM, KOMET-007, ASC4FIRST, ASC2ESCALATE - Dr. Jorge Cortes
Jorge Cortes, MD, shares data presented at ASH 2017 regarding bosutinib in CML treatment
Ever Changing Algorithms in CML Treatment Featuring Dr. Jorge Cortes (Georgia Cancer Center)
ASCO24 Direct Highlights | Jorge Cortes, MD
Interview Jorge Cortes
Jorge E Cortes MD, EHA 2019 – Advances in the Treatment and Management of Acute Myeloid Leukaemia
Jorge Cortés Show reel
Georgia CEO Network - Dr. Jorge Cortes on his vision for the Georgia Cancer Center's future
A GOZAR LA NAVIDAD de JORGE CORTES
Georgia CEO Network - Dr. Jorge Cortes on the Cancer Center's role in improving care and prevention
2025 Highlights of ASH with Dr. Jorge Cortes
Treating and Managing Chronic Myeloid Leukemia (CML) in 2025: Dr. Jorge Cortes
22/9 - WORLD CML DAY - Dr. JORGE CORTES - USA
Jorge Cortes, MD, on the evolution of CAR-T cell therapies in hematologic malignancies management
Jorge Cortes, MD, on how generic imatinib is being adopted as an alternative to branded imatinib
What are the sensitivities of different CML therapies to various mutations including T315I?
Resource-Aware Control for the Design of Accelerated Optimization Algorithms - Jorge Cortes
Jorge Cortes, MD, provides thoughts on what the impact of the OPTIC study will be on CML patients
Field Report: Dr. Jorge Cortés on using the DeepSee Submersible for Research
JORGE CORTES #ABADPRODUCCIONES
